U.S. Office-based Labs Market To Reach $35.21 Billion By 2033

U.S. Office-based Labs Market Growth & Trends

The U.S. office-based labs market size is expected to reach USD 35.21 billion by 2033 expanding at a CAGR of 11.16% from 2025 to 2033, according to a new report by Grand View Research, Inc. The increasing prevalence of vascular diseases and rising preference for minimally invasive procedures in outpatient settings are the major factors driving the demand for office-based labs (OBL) in the U.S. High prevalence of risk factors, such as smoking, high blood pressure, diabetes, and high cholesterol, along with the growing geriatric population, is expected to increase the incidence of Peripheral Artery Diseases (PADs).

The resultant surge in the number of procedures performed for their treatment is anticipated to fuel the market growth during the forecast period. The rapidly transitioning healthcare delivery scenario is driving key market players to transform their business models to achieve maximum benefit from ongoing transitions. A key driving factor supporting the changing preferences of consumers is the cost-effectiveness of OBL. Some of the key reasons to visit office-based labs are preventive care, underlying chronic condition, pre/post-surgery care, and injuries/trauma. In addition, high patient satisfaction with a focused and dedicated team of doctors is expected to boost the market in the U.S.

During the COVID-19 pandemic, private practices, such as OBLs, postponed elective procedures, which included elective angioplasty or elective rotational atherectomy during transcatheter aortic valve implantation, or any other elective vascular operations performed under general or peripheral anesthesia. According to the findings published by The Commonwealth Fund, in August 2020, the total number of ambulatory practices witnessed a decline of 60% and recorded a significant decline in provider office visits. Many OBLs in the U.S. have reported a sharp decline in their businesses, however, some of them are offering testing facilities and post-respiratory therapy.

 Request a free sample copy or view the report summary: U.S. Office-based Labs Market Report

U.S. Office-based Labs Market Report Highlights

• The single specialty segment held the largest revenue share of 41.55% in 2024. Single-specialty labs within the U.S. office-based labs market are witnessing robust growth, primarily driven by the rising demand for focused and high-efficiency care delivery in specific therapeutic areas such as vascular, endovascular, orthopedic, ophthalmologic, and pain management procedures.

• The peripheral vascular intervention (PAD) segment held the largest revenue share of 36.84% in 2024. PAD is caused by the hardening of arteries or partial blockage of arteries due to the formation of plaque.

• In the specialist category, vascular surgeons are the leading service providers in OBL. All major vascular surgeries, such as aortic, mesenteric, renal, subclavian, iliofemoral, tibial, and pedal, are being performed by vascular surgeons in office settings

• Mergers & and acquisitions, technological advancements, and new product launches are some of the strategies followed by major players. For Instance, in May 2021, Surgery Partners entered into a strategic partnership with UCI Health to develop & expand access to outpatient surgical facilities and enhance patient outcome

U.S. Office-based Labs Market Segmentation

Grand View Research has segmented the U.S. office-based labs market report based on service, modality, and specialist:

U.S. office-based labs Services Outlook (Revenue, USD Million, 2021 - 2033)

• Peripheral Vascular Intervention

• Atherectomy

  • Vascular Angioplasty

  • Stenting

  • Other PVI

• Endovascular Interventions

• Cardiac

• Interventional radiology

  • Uterine Fibroid Embolization (UFE)

  • Prostate Artery Embolization (PAE)

  • Y90/Oncology

  • Other IR

• Venous

  • RFA (Radiofrequency Ablation) and EVLT (Endovenous Laser Therapy)

  • Sclerotherapy/Glue

  • Venous Stenting

  • Other Deep Vein

• Others

U.S. office-based labs Services Outlook (Number of Procedures, 2021 - 2033)

• Peripheral Vascular Intervention

  • Atherectomy

  • Vascular Angioplasty

  • Stenting

  • Other PVI

• Endovascular Interventions

• Cardiac

• Interventional radiology

  • Uterine Fibroid Embolization (UFE)

  • Prostate Artery Embolization (PAE)

  • Y90/Oncology

  • Other IR

• Venous

  • RFA (Radiofrequency Ablation) and EVLT (Endovenous Laser Therapy)

  • Sclerotherapy/Glue

  • Venous Stenting

  • Other Deep Vein

• Others

U.S. office-based labs Modality Outlook (Revenue, USD Million, 2021 - 2033)

• Single Specialty

• Multi-Specialty

• Hybrid

U.S. office-based labs Specialist Outlook (Revenue, USD Million, 2021 - 2033)

• Vascular Surgeons

• Interventional Cardiologists

• Interventional Radiologists

• Others

Key Players of U.S. Office-based Labs Market

• Suppliers

• Koninklijke Philips N.V.

• GE Healthcare

• Siemens Healthineers AG

• Medtronic PLC

• Boston Scientific Corporation

• Abbott

• Service Providers

• Envision Healthcare Corporation (KKR)

• Surgical Care Affiliates (SCA)

• Surgery Partners

• Cardiovascular Coalition

• TH Medical

• Vascular Care Group

• Coastal Vascular Institute